AtriCure to Participate in the Stifel 2023 Healthcare Conference

Rhea-AI Summary

AtriCure, Inc. will be participating in the Stifel 2023 Healthcare Conference. The company's management will be participating in a fireside chat on November 14, 2023, at 10:55 a.m. EST. Interested parties can access a live audio webcast on the company's website.

MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Stifel 2023 Healthcare Conference.

AtriCure’s management is scheduled to participate in a fireside chat on Tuesday, November 14, 2023, at 10:55 a.m. Eastern Standard Time. Interested parties may access a live audio webcast by visiting the “Investors” section of the company’s website at https://ir.atricure.com.

About AtriCure

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator^® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip^® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure’s cryoICE cryoSPHERE^® probe is cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on Twitter @AtriCure.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231031704723/en/

Angie Wirick

AtriCure, Inc.

Chief Financial Officer

(513) 755-5334

awirick@atricure.com

Lynn Lewis or Marissa Bych

Gilmartin Group

Investor Relations

lynn@gilmartinir.com

marissa@gilmartinir.com

Source: AtriCure, Inc.

FAQ

What is AtriCure, Inc.?

AtriCure, Inc. is a leading innovator in surgical treatments for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management.

What is the Stifel 2023 Healthcare Conference?

The Stifel 2023 Healthcare Conference is an upcoming event where healthcare companies will participate to discuss their businesses and industry trends.

When is AtriCure's fireside chat scheduled?

AtriCure's fireside chat is scheduled for Tuesday, November 14, 2023, at 10:55 a.m. EST.

How can interested parties access the live audio webcast?

Interested parties can access the live audio webcast by visiting the 'Investors' section of AtriCure's website at https://ir.atricure.com.